BioSuperior™ Anti-CD47 Therapeutic Antibody (AVI-105) from AbVision Inc
AbVision developed AVI-105, the biosuperior anti-CD47 therapeutic antibody against cancer! MILPITAS, CA, UNITED STATES, May 18, 2020 /EINPresswire.com/ -- AbVision, Inc., an innovative biopharmaceutical company, announced today that the Company has …